Gabriella Maioli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology.
Journal: Annals of the rheumatic diseases
Published: June 09, 2025
ChatGPT vs rheumatologists: cross-sectional study on accuracy and patient perception of AI-generated information for psoriatic arthritis.
Journal: Annals of the rheumatic diseases
Published: May 26, 2025
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs.
Journal: Drugs
Published: June 03, 2024
Whole-Blood RNA Sequencing Profiling of Patients With Rheumatoid Arthritis Treated With Tofacitinib.
Whole-Blood RNA Sequencing Profiling of Patients With Rheumatoid Arthritis Treated With Tofacitinib.
Journal: ACR open rheumatology
Published: March 23, 2024
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients.
Journal: Arthritis research & therapy
Published: March 04, 2024
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience.
Journal: Clinical and experimental rheumatology
Published: December 28, 2023
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers.
Journal: Autoimmunity reviews
Published: December 10, 2023
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events.
Journal: Frontiers in immunology
Published: May 18, 2023
Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis.
Journal: Expert opinion on drug discovery
Published: June 27, 2022
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.
Journal: Frontiers in medicine
Published: April 19, 2022
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations.
Journal: Frontiers in immunology
Published: February 10, 2022
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.
Journal: Frontiers in medicine
Published: January 08, 2022
Last Updated: 09/26/2026